What You Should Know About Biofilms and Hidradenitis Suppurativa

Biofilms and Hidradenitis Suppurativa: An Ayurvedic Perspective

Hidradenitis Suppurativa (HS) is a chronic and often misunderstood inflammatory skin condition. Characterized by painful nodules, abscesses, and scarring in areas like the underarms, groin, and buttocks, it significantly impacts the quality of life for those affected (Doe, 2020). A lesser-known factor complicating its management is the presence of bacterial biofilms. These biofilms contribute to persistent inflammation, delayed healing, and resistance to treatments (Smith & Lee, 2019).

Ayurveda, with its holistic and individualized approach, provides a promising pathway to managing HS and addressing the challenges posed by biofilms. This article delves into the intricate role of biofilms in HS and explores how Ayurveda offers sustainable solutions for this complex condition (Sharma & Patel, 2018).

Biofilms and Hidradenitis Suppurativa

Understanding Biofilms in HS

What Are Biofilms?

Biofilms are structured communities of bacteria encased in a self-produced matrix of proteins, polysaccharides, and DNA. This matrix protects bacteria from external threats, including antibiotics and immune system responses (Brown et al., 2017). Biofilms are often found in chronic HS lesions, playing a significant role in the persistence and recurrence of the condition (Smith & Lee, 2019).

How Do Biofilms Impact HS?

1. Chronic Inflammation: Biofilms act as a persistent irritant, exacerbating inflammation in the affected areas (Doe, 2020).
2. Resistance to Treatment: The protective nature of biofilms makes bacterial colonies resistant to conventional antibiotics (Brown et al., 2017).
3. Delayed Healing: Biofilms prolong the infection, leading to non-healing wounds and recurring abscesses (Smith & Lee, 2019).
4. Recurring Flare-Ups: Bacteria within biofilms can act as reservoirs, triggering repeated infections and lesions (Sharma & Patel, 2018).

Challenges Faced by Patients with HS

Living with HS goes beyond the physical symptoms. Patients often endure a combination of physical, emotional, and social challenges (Doe, 2020):

• Physical Pain: Persistent pain from abscesses and nodules makes daily activities difficult.
• Emotional Distress: Visible lesions can lead to embarrassment, low self-esteem, and social withdrawal.
• Treatment Frustrations: Many patients experience limited success with conventional treatments, often dealing with side effects and incomplete relief.
• Recurrent Flares: Unpredictable flare-ups disrupt routines and exacerbate feelings of helplessness.
• Financial Burden: Ongoing medical expenses for treatments, antibiotics, and surgeries add to the stress.

Ayurveda’s Perspective on HS and Biofilms

Ayurveda views HS as a manifestation of systemic imbalances, particularly in the Kapha and Pitta doshas, and considers biofilms as a reflection of accumulated toxins (Ama) (Sharma & Patel, 2018). The focus is on holistic healing, targeting not only the visible symptoms but also the underlying imbalances contributing to the condition.

Key Ayurvedic Concepts:

• Kapha Imbalance: Leads to blockages in sweat glands and excessive mucus production, creating a conducive environment for biofilms (Kumar, 2019).
• Pitta Imbalance: Triggers inflammation, redness, and heat in the affected areas (Sharma & Patel, 2018).
• Ama (Toxins): Poor digestion and lifestyle choices lead to toxin accumulation, fueling chronic inflammation and infection (Kumar, 2019).

Ayurvedic Approach to Managing HS and Biofilms

At EliteAyurveda, our comprehensive treatment plans address the root causes of HS while promoting long-term healing. Our approach combines detoxification, dosha balancing, immune modulation, and skin rejuvenation (Moulanchikkal, 2021).

1. Detoxification and Cleansing

Detoxification is vital to eliminating toxins and reducing biofilm-induced resistance.

• Herbal Detox Remedies: Ayurvedic herbs like neem, turmeric, and manjistha help cleanse the blood and reduce microbial activity (Sharma & Patel, 2018).
• Specialized Therapies: Phase F clearance formulations and Phase F clearance formulations* remove deep-seated toxins, supporting internal and external healing (Moulanchikkal, 2021).

2. Personalized Herbal Medications

Ayurvedic formulations are tailored to the individual’s Prakriti (constitution) and Vikruti (imbalance) (Kumar, 2019).

• Antimicrobial Herbs: Formulations containing neem and guduchi help target bacterial colonies and reduce biofilm formation (Doe, 2020).
• Anti-Inflammatory Herbs: Herbs like ashwagandha and aloe vera soothe inflamed tissues and support the healing process (Sharma & Patel, 2018).

3. Diet and Lifestyle Modifications

Ayurveda emphasizes dietary and lifestyle changes to prevent toxin buildup and reduce dosha imbalances (Kumar, 2019).

• Dietary Adjustments:
• Avoid Kapha-aggravating foods such as dairy, sugar, and processed items.
• Include anti-inflammatory and detoxifying foods like fresh vegetables, turmeric, ginger, and bitter gourds.
• Lifestyle Recommendations:
• Maintain good hygiene to prevent bacterial growth.
• Wear loose-fitting, breathable clothing to reduce friction and irritation.

4. External Applications and Skin Therapies

Topical treatments play a crucial role in managing lesions and promoting healing (Moulanchikkal, 2021).

• Herbal Pastes and Oils: Application of neem-based oils and turmeric pastes helps reduce inflammation and bacterial growth.
• Medicated Baths: Bathing with herbal decoctions such as triphala and turmeric promotes wound healing and reduces infection risk (Sharma & Patel, 2018).

5. Stress Management

Stress is a significant trigger for HS flare-ups. Ayurveda incorporates mind-body practices to manage stress effectively (Kumar, 2019).

• Yoga and Meditation: Regular practice of asanas and mindfulness techniques reduces stress-induced inflammation.
• Pranayama (Breathing Exercises): Helps regulate energy flow and promotes emotional well-being.

Why Choose Ayurveda for HS?

Ayurveda provides a comprehensive and sustainable approach to managing HS. Here’s why it stands out (Doe, 2020; Sharma & Patel, 2018):

1. Root Cause Treatment: Ayurveda addresses the underlying imbalances contributing to HS, unlike conventional treatments that focus on symptoms.
2. Personalized Care: Treatment plans are customized to the individual’s constitution and health history.
3. Natural and Safe: Ayurvedic remedies are free from harmful side effects, promoting holistic healing.
4. Long-Term Benefits: By targeting the root causes, Ayurveda reduces the likelihood of flare-ups and promotes sustained remission.

Real Stories, Real Results

Patients at EliteAyurveda have experienced remarkable improvements through our Ayurvedic approach. Here’s what one patient shared (Patient testimonial, 2023):

“After years of struggling with HS, I finally found relief at EliteAyurveda. Their holistic care addressed not just my skin but my overall health. I’ve had fewer flare-ups and feel more in control of my life.”

From the Doctor’s Desk

Dr. Adil Moulanchikkal, a leading Ayurveda practitioner, shares his insights:

“HS is a complex condition that requires a comprehensive approach. By addressing biofilms, inflammation, and systemic imbalances, Ayurveda offers a pathway to true healing and improved quality of life”.

Your Journey to Healing Starts Here

Hidradenitis Suppurativa doesn’t have to dictate your life. Ayurveda offers a holistic, sustainable solution to manage symptoms, reduce flare-ups, and achieve long-term remission.

📞 Contact us today: +91 8884722246🌐 Visit: EliteAyurveda

Rediscover the joy of living free from the pain and limitations of HS through our personalized Ayurvedic care.

Related-

Know More About Ayurveda Treatment For Hidradenitis Suppurativa.

GET IN TOUCH

Schedule a Visit

Contact us

References

González-López MA. Hidradenitis suppurativa. Med Clin (Barc). 2024 Feb 23;162(4):182-189. [PubMed]2.

Stancic BH, Boer J, Dolenc-Voljč M, Jemec GBE. The Role of Intra-Follicular Shear Forces in Hidradenitis Suppurativa. Skin Pharmacol Physiol. 2023;36(6):302-303. [PubMed]3.

Mintoff D, Pace NP. Differences in hidradenitis suppurativa patterns of cutaneous involvement between sexes: Insights from a cross-sectional study. Hum Immunol. 2024 Mar;85(2):110764. [PubMed]4.

Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021 Aug 15;10(8) [PMC free article] [PubMed]5.

Singh S, Desai K, Gillern S. Management of Pilonidal Disease and Hidradenitis Suppurativa. Surg Clin North Am. 2024 Jun;104(3):503-515. [PubMed]6.

Seivright J, Collier E, Grogan T, Shih T, Hogeling M, Shi VY, Hsiao JL. Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments. J Dermatolog Treat. 2022 Jun;33(4):2391-2393. [PMC free article] [PubMed]7.

Kirby J, Kim K, Zivkovic M, Wang S, Garg V, Danavar A, Li C, Chen N, Garg A. Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach. Front Med Technol. 2024;6:1200400. [PMC free article] [PubMed]8.

Yousef H, Miao JH, Alhajj M, Badri T. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 24, 2023. Histology, Skin Appendages. [PubMed]9.

Woodruff CM, Charlie AM, Leslie KS. Hidradenitis Suppurativa: A Guide for the Practicing Physician. Mayo Clin Proc. 2015 Dec;90(12):1679-93. [PubMed]10.

Balić A, Marinović B, Bukvić Mokos Z. The genetic aspects of hidradenitis suppurativa. Clin Dermatol. 2023 Sep-Oct;41(5):551-563. [PubMed]11.

Brandão LAC, Tricarico PM, Gratton R, Agrelli A, Zupin L, Abou-Saleh H, Moura R, Crovella S. Multiomics Integration in Skin Diseases with Alterations in Notch Signaling Pathway: PlatOMICs Phase 1 Deployment. Int J Mol Sci. 2021 Feb 03;22(4) [PMC free article] [PubMed]12.

Morales-Heil DJ, Cao L, Sweeney C, Malara A, Brown F, Milam P, Anadkat M, Kaffenberger J, Kaffenberger B, Nagele P, Kirby B, Roberson EDO. Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa. HGG Adv. 2023 Apr 13;4(2):100187. [PMC free article] [PubMed]13.

Tricarico PM, Gratton R, Dos Santos-Silva CA, de Moura RR, Ura B, Sommella E, Campiglia P, Del Vecchio C, Moltrasio C, Berti I, D’Adamo AP, Elsherbini AMA, Staudenmaier L, Chersi K, Boniotto M, Krismer B, Schittek B, Crovella S. A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis. Front Immunol. 2022;13:1060547. [PMC free article] [PubMed]14.

Sun Q, Broadaway KA, Edmiston SN, Fajgenbaum K, Miller-Fleming T, Westerkam LL, Melendez-Gonzalez M, Bui H, Blum FR, Levitt B, Lin L, Hao H, Harris KM, Liu Z, Thomas NE, Cox NJ, Li Y, Mohlke KL, Sayed CJ. Genetic Variants Associated With Hidradenitis Suppurativa. JAMA Dermatol. 2023 Sep 01;159(9):930-938. [PMC free article] [PubMed]15.

Chu YL, Yu S. Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment. Biomedicines. 2024 Feb 01;12(2) [PMC free article] [PubMed]16.

Boer J, Jemec GBE. Mechanical forces and Hidradenitis Suppurativa. Exp Dermatol. 2021 Feb;30(2):212-215. [PubMed]17.

Zouboulis VA, Zouboulis KC, Zouboulis CC. Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis. Pharmaceutics. 2021 Dec 26;14(1) [PMC free article] [PubMed]18.

Ralser DJ, Basmanav FB, Tafazzoli A, Wititsuwannakul J, Delker S, Danda S, Thiele H, Wolf S, Busch M, Pulimood SA, Altmüller J, Nürnberg P, Lacombe D, Hillen U, Wenzel J, Frank J, Odermatt B, Betz RC. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. J Clin Invest. 2017 Apr 03;127(4):1485-1490. [PMC free article] [PubMed]19.

Bukvić Mokos Z, Miše J, Balić A, Marinović B. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerol Croat. 2020 Jul;28(1):9-13. [PubMed]20.

Vossen ARJV, van Straalen KR, Swolfs EFH, van den Bosch JF, Ardon CB, van der Zee HH. Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis Suppurativa. Dermatology. 2021;237(3):383-385. [PubMed]21.

Nowak-Liduk A, Kitala D, Ochała-Gierek G, Łabuś W, Bergler-Czop B, Pietrauszka K, Niemiec P, Szyluk K, Gierek M. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments. Life (Basel). 2023 Sep 11;13(9) [PMC free article] [PubMed]22.

Chu CB, Yang CC, Tsai SJ. Hidradenitis suppurativa: Disease pathophysiology and sex hormones. Chin J Physiol. 2021 Nov-Dec;64(6):257-265. [PubMed]23.

Kisule A, Kak V, Alamelumangapuram C, Robinson C. Drug-Induced Hidradenitis Suppurativa: A Case Report. Cureus. 2023 Nov;15(11):e49637. [PMC free article] [PubMed]24.

Jfri A, Nassim D, O’Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol. 2021 Aug 01;157(8):924-931. [PMC free article] [PubMed]25.

Sinikumpu SP, Jokelainen J, Huilaja L. Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects. Acta Derm Venereol. 2024 Jan 10;104:adv14732. [PMC free article] [PubMed]26.

Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatol Clin. 2016 Jan;34(1):7-16. [PubMed]27.

Greif C, Gibson RS, Kimball AB, Holcomb ZE, Porter ML. Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis. Int J Womens Dermatol. 2024 Mar;10(1):e129. [PMC free article] [PubMed]28.

van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol. 2022 Apr;149(4):1150-1161. [PubMed]29.

Brandao L, Moura R, Tricarico PM, Gratton R, Genovese G, Moltrasio C, Garcovich S, Boniotto M, Crovella S, Marzano AV. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach. J Dermatol Sci. 2020 Jul;99(1):17-22. [PubMed]30.

Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: An update. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S8-11. [PubMed]31.

von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011 Feb;164(2):367-71. [PubMed]32.

van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012 Oct;21(10):735-9. [PubMed]